Quick Answer
AMGEN INC reported Revenue (ASC 606) of $36.75 billion for fiscal year 2025.
AMGEN INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $36.75B | +10.0% |
| 2024 | $33.42B | +18.6% |
| 2023 | $28.19B | +7.1% |
| 2022 | $26.32B | +1.3% |
| 2021 | $25.98B | +2.2% |
| 2020 | $25.42B | +8.8% |
| 2019 | $23.36B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.56B | +12.4% | +4.1% |
| June 30, 2025 | $9.18B | +9.4% | +12.6% |
| March 31, 2025 | $8.15B | +9.4% | -4.2% |
| September 30, 2024 | $8.50B | +23.2% | +1.4% |
| June 30, 2024 | $8.39B | +20.1% | +12.6% |
| March 31, 2024 | $7.45B | +22.0% | +7.9% |
| September 30, 2023 | $6.90B | +3.8% | -1.2% |
| June 30, 2023 | $6.99B | +5.9% | +14.4% |
- AMGEN INC showed an increase of +10.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2019–2025 period, AMGEN INC’s revenue (asc 606) has grown by 57.3% (from $23.36 billion to $36.75 billion).
- The most recent figure is from AMGEN INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: